Teradyne (TER) Cost of Revenue (2009 - 2026)

Teradyne has reported Cost of Revenue for 18 years, with the latest figure at $534.4 million in Q2 2026.

• Cost of Revenue for Q2 2026 came in at $534.4 million, up 91.68% year-over-year; the trailing twelve-month figure through Jun 2026 was $1.8 billion (up 57.46% YoY), and the FY2025 annual result was $1.3 billion, up 13.81% from the prior year.
• Cost of Revenue rose to $534.4 million in Q2 2026, from $501.5 million in the prior quarter.
• Over five years, Cost of Revenue peaked at $534.4 million in Q2 2026 and troughed at $260.5 million in Q1 2024.
• A 5-year average of $331.5 million and a median of $304.7 million in 2023 frame the typical range for Cost of Revenue.
• The widest annual swing landed in 2022, when Cost of Revenue fell 23.79%; it then soared 91.68% in 2026.
• A 5-year view of Cost of Revenue shows it stood at $311.4 million in 2022, then fell by 6.53% to $291.1 million in 2023, then advanced by 5.0% to $305.6 million in 2024, then jumped by 51.72% to $463.6 million in 2025, then gained by 15.25% to $534.4 million in 2026.
• Per Business Quant data, the three most recent Cost of Revenue figures were $534.4 million in Q2 2026, $501.5 million in Q1 2026, and $463.6 million in Q4 2025.